EFSA Establishes 250mg Daily Limit for Quercetin Following Novel Food Safety Review
EFSA Panel on Nutrition finalized a safety assessment capping quercetin intake at 250mg per day for adults, necessitating formula changes for high-dose immune products.
The European Food Safety Authority issued a final scientific opinion on quercetin dihydrate today, setting a maximum safe intake level that will force immediate revisions for several premium immune and longevity brands.
New Safety Caps and Formula Impacts
Common dosages on the EU market currently range from 500mg to 1000mg per serving. The new 250mg limit is based on toxicology data regarding long term kidney stress. If your Q4 production runs include high dose quercetin, you must split doses across multiple capsules or reduce the total concentration to remain compliant with upcoming Annex III amendments.
Pricing and Supply Chain Shifts
The market for 95 percent purity quercetin dihydrate is currently stable at 42 EUR per kg. However, I expect a short term surplus of high concentration raw material as brands scramble to reformulate. This is the time to negotiate lower rates for 2027 contracts.
- Maximum daily dose set at 250mg for adults excluding pregnant women
- Mandatory warning labels required for products containing over 50mg per dose
- Current raw material spot price sits at 42 EUR per kg
- Reformulation deadline expected within 12 months of formal Union List entry
Strategic Recommendation
If you are currently selling 500mg capsules, pivot to a complex formula. Blend 200mg of quercetin with Zinc and Vitamin C to maintain the premium price point while staying under the safety ceiling. Do not wait for the grace period to end because retailers are already auditing COAs against this opinion.
Tell Jake what you need. Real EU supplier offers within a day.